“…Enzymatic transformations have emerged as a competitive alternative in asymmetric synthesis due to their high selectivity, renewability, and mild catalytic conditions. , In particular, the advent of directed evolution and rational design technologies has revolutionized the realm of enzyme catalysis, empowering enzymes to proficiently convert many otherwise recalcitrant substrates. − Indeed, the enzymatic enantioselective synthesis of chiral diarylmethanols has now also been documented. − Candida antarctica lipase B (CALB) mutants have been designed with enhanced enantioselectivity in kinetic resolution of diarylmethanol acetates, enabling the synthesis of phenyl-pyridylmethanols in high enantiomeric excess (ee) values (Scheme , eq 2c). , Besides, alcohol dehydrogenases (ADHs) and ketoreductases (KREDs) are often used for chiral alcohol synthesis by reduction of prochiral ketones. Recent developments in the molecular biology field allowed the emergence of various valuable mutations of ADHs, leading to efficient biocatalysts that can be applied toward bulky–bulky prochiral substrates, which are hardly accepted by the wild-type enzymes, including ADHs from Kluyveromyces polyspora ( Kp ADHs), , Thermoanaerobacter brockii ( TbS ADH), Stenotrophomonas maltophilia ( Cg ADH), and Lactobacillus kefiri ( Lk ADH) . For example, Zhou, Ni et al achieved the enantioselective reduction of diaryl ketones using native and engineered Kp ADHs (Scheme , eq 2b) .…”